LAG-3 Antibody [17B4] (ATTO 590)
Product Specifications
Background
Lymphocyte activation gene 3 (LAG-3; CD223) plays an important role in negatively regulating T cell proliferation, function and homeostasis. It is required for maximal natural and induced regulatory T cell (Treg) function. LAG-3 is closely related to the T cell co-receptor CD4 and binds to MHC class II molecules but with a significantly higher affinity than CD4.
NCBI Gene ID
3902
Swiss Prot
P18627
Accession Number
251757512
Host
Mouse
Reactivity
Human
Immunogen
Synthetic peptide corresponding to 30 aa in the N-terminus of human LAG-3.
Clonality
Monoclonal
Clone
17B4
Conjugation
ATTO 590
Type
Primary Antibodies
Field of Research
Immunology, Innate Immunity
Purification
>95% (SDS-PAGE)
Concentration
0.5 mg/ml
Buffer
Liquid. In PBS containing 0.02% sodium azide.
Modification
None
Shipping Conditions
Blue Ice
Storage Conditions
Keep conjugated formats at +4˚ C. Stable for at least 1 year after receipt when stored at +4˚ C.
Fragment
IgG1
Specificity
Recognizes human LAG-3.
Symbol
LAG3
NCBI Official Name
Lymphocyte activating 3
NCBI Organism
Homo sapiens
Other Product Names
Lymphocyte Activation Gene-3; FDC Protein; CD223
Tested Applications
ICC
Protein ID
P18627
Physical Properties
Liquid
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS6397991-01 0.1 mL
UGT1A9 (UDP-glucuronosyltransferase 1A9, UDP-glucuronosyltransferase 1-9, UDPGT 1-9, UGT1*9, UGT1-09, UGT1.9, UDP-glucuronosyltransferase 1-I, UGT-1I, UGT1I, GNT1, lugP4, UGT1) (MaxLight 490)
Sign In for Pricing
View Details MBS6397991-02 5x 0.1 mL
UGT1A9 (UDP-glucuronosyltransferase 1A9, UDP-glucuronosyltransferase 1-9, UDPGT 1-9, UGT1*9, UGT1-09, UGT1.9, UDP-glucuronosyltransferase 1-I, UGT-1I, UGT1I, GNT1, lugP4, UGT1) (MaxLight 490)
Sign In for Pricing
View Details